143 related articles for article (PubMed ID: 37310904)
1. Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status.
Yamamoto M; Miyauchi A; Ito Y; Fujishima M; Sasaki T; Kudo T
Thyroid; 2023 Oct; 33(10):1182-1189. PubMed ID: 37310904
[No Abstract] [Full Text] [Related]
2. Effect of TSH levels during active surveillance of PTMC according to age.
Kim HI; Jin M; Ko NG; Oh YL; Shin JH; Kim JH; Kim JS; Jeon MJ; Kim TY; Kim SW; Kim WB; Chung JH; Shong YK; Kim WG; Kim TH
Endocr Relat Cancer; 2022 Mar; 29(4):191-200. PubMed ID: 35099407
[TBL] [Abstract][Full Text] [Related]
3. Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea.
Lee EK; Moon JH; Hwangbo Y; Ryu CH; Cho SW; Choi JY; Chung EJ; Jeong WJ; Jung YS; Ryu J; Kim SJ; Kim MJ; Kim YK; Lee CY; Lee JY; Yu HW; Hah JH; Lee KE; Lee YJ; Park SK; Park DJ; Kim JH; Park YJ
Thyroid; 2022 Nov; 32(11):1328-1336. PubMed ID: 36205563
[No Abstract] [Full Text] [Related]
4. High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance.
Kim HI; Jang HW; Ahn HS; Ahn S; Park SY; Oh YL; Hahn SY; Shin JH; Kim JH; Kim JS; Chung JH; Kim TH; Kim SW
J Clin Endocrinol Metab; 2018 Feb; 103(2):446-451. PubMed ID: 29211863
[TBL] [Abstract][Full Text] [Related]
5. Assesment of attainment of recommended TSH levels and levothyroxine compliance in differentiated thyroid cancer patients.
Yavuz DG; Yazan CD; Hekimsoy Z; Aydin K; Gokkaya N; Ersoy C; Akalın A; Topaloglu O; Aydogan BI; Dilekci ENA; Alphan Uc Z; Cansu GB; Ozsari L; Iyidir OT; Olgun ME; Keskin L; Mert M; Can B; Gungor K; Galip T; Cantürk Z; Elbuken G; Pekkolay Z; Kutbay NO; Yorulmaz G; Kalkan AT; Unsal YA; Yay A; Karagun B; Bozkur E
Clin Endocrinol (Oxf); 2022 Dec; 97(6):833-840. PubMed ID: 35639050
[TBL] [Abstract][Full Text] [Related]
6. Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression.
Na YM; Cho JS; Park MH
Anticancer Res; 2021 Nov; 41(11):5713-5721. PubMed ID: 34732444
[TBL] [Abstract][Full Text] [Related]
7. Thyroid-Stimulating Hormone, Age, and Tumor Size are Risk Factors for Progression During Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma in Adults.
Ito Y; Miyauchi A; Fujishima M; Noda T; Sano T; Sasaki T; Kishi T; Nakamura T
World J Surg; 2023 Feb; 47(2):392-401. PubMed ID: 36182976
[TBL] [Abstract][Full Text] [Related]
8. Active Surveillance Versus Immediate Surgery for Low-Risk Papillary Thyroid Microcarcinoma Patients in South Korea: A Cost-Minimization Analysis from the MAeSTro Study.
Kim K; Choi JY; Kim SJ; Lee EK; Lee YK; Ryu JS; Lee KE; Moon JH; Park YJ; Cho SW; Park SK
Thyroid; 2022 Jun; 32(6):648-656. PubMed ID: 35570657
[No Abstract] [Full Text] [Related]
9. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
Ito M; Kawasaki M; Danno H; Kohsaka K; Nakamura T; Hisakado M; Yoshioka W; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123
[No Abstract] [Full Text] [Related]
10. Tumor volume-doubling rate is negatively associated with patient age in papillary thyroid microcarcinomas under active surveillance.
Yamamoto M; Miyauchi A; Ito Y; Fujishima M; Sasaki T; Kudo T
Surgery; 2024 Apr; 175(4):1089-1094. PubMed ID: 38142143
[TBL] [Abstract][Full Text] [Related]
11. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation.
Ito Y; Miyauchi A; Kihara M; Higashiyama T; Kobayashi K; Miya A
Thyroid; 2014 Jan; 24(1):27-34. PubMed ID: 24001104
[TBL] [Abstract][Full Text] [Related]
12. Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma.
Sasaki T; Miyauchi A; Ito Y; Kudo T; Kanemura N; Sano T; Kawano S; Yamamoto M; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Miya A
Thyroid; 2021 Feb; 31(2):217-223. PubMed ID: 32664805
[No Abstract] [Full Text] [Related]
13. [Increase in TSH levels in thyroid carcinoma patients after withdrawal of suppressive levothyroxine medication].
Hackländer S; Voth E; Schicha H
Nuklearmedizin; 1996 Oct; 35(5):170-4. PubMed ID: 9005413
[TBL] [Abstract][Full Text] [Related]
14. Association between preoperative serum TSH and tumor status in patients with papillary thyroid microcarcinoma.
Mao A; An N; Wang J; Wu Y; Wang T; Wang Z; Guan H; Wang J
Endocrine; 2021 Sep; 73(3):617-624. PubMed ID: 33755880
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience.
Miyauchi A; Ito Y; Fujishima M; Miya A; Onoda N; Kihara M; Higashiyama T; Masuoka H; Kawano S; Sasaki T; Nishikawa M; Fukata S; Akamizu T; Ito M; Nishihara E; Hisakado M; Kosaka K; Hirokawa M; Hayashi T
Thyroid; 2023 Jul; 33(7):817-825. PubMed ID: 37166389
[No Abstract] [Full Text] [Related]
16. Delayed TSH recovery after dose adjustment during TSH-suppressive levothyroxine therapy of thyroid cancer.
Kim HI; Kim TH; Kim H; Kim YN; Jang HW; Kim JH; Hur KY; Chung JH; Kim SW
Clin Endocrinol (Oxf); 2017 Sep; 87(3):286-291. PubMed ID: 28375573
[TBL] [Abstract][Full Text] [Related]
17. Levothyroxine or minimally invasive therapies for benign thyroid nodules.
Bandeira-Echtler E; Bergerhoff K; Richter B
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD004098. PubMed ID: 24941398
[TBL] [Abstract][Full Text] [Related]
18. Papillary thyroid microcarcinomas: big decisions for a small tumor.
Haymart MR; Cayo M; Chen H
Ann Surg Oncol; 2009 Nov; 16(11):3132-9. PubMed ID: 19653044
[TBL] [Abstract][Full Text] [Related]
19. Postintervention serum TSH levels may be useful to differentiate patients who should undergo levothyroxine suppressive therapy after thyroid surgery for multinodular goiter in a region with moderate iodine deficiency.
Rotondi M; Amato G; Del Buono A; Mazziotti G; Manganella G; Biondi B; Sinisi AM; Santini L; Bellastella A; Carella C
Thyroid; 2000 Dec; 10(12):1081-5. PubMed ID: 11201853
[TBL] [Abstract][Full Text] [Related]
20. Effects of Chronic Suppression or Oversuppression of Thyroid-Stimulating Hormone on Psychological Symptoms and Sleep Quality in Patients with Differentiated Thyroid Cancer.
Altuntaş SÇ; Hocaoğlu Ç
Horm Metab Res; 2021 Oct; 53(10):683-691. PubMed ID: 34607367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]